Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal sufentanil for analgesia in gastrointestinal cancer surgery
IRCT20210129050174N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sufentanil in postoperative pain, sponsored by Mashhad University of Medical Sciences. Primary endpoint: Postoperative analgesia quality. Started May 2021; status: completed.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20210129050174N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210129050174N1.